Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00538564
Recruitment Status : Withdrawn (Trial closed just prior to study receiving Investigational Review Board approval)
First Posted : October 2, 2007
Last Update Posted : September 21, 2016
Eli Lilly and Company
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : August 2009